ESSA Pharma
+$0.04 (+0.14%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
You can buy or sell ESSA Pharma and other stocks, options, and ETFs commission-free!
About EPIX
ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival.
CEO
David R. Parkinson
Employees
25
Headquarters
Vancouver, British Columbia
Founded
2009
EPIX Key Statistics
Market Cap
1.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
248.10K
High Today
$29.90
Low Today
$28.69
Open Price
$28.88
Volume
61.89K
52 Week High
$32.69
52 Week Low
$4.36
EPIX Earnings
-$0.45
-$0.30
-$0.15
-$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
-$0.36 per share